Literature DB >> 9826051

Capillary haemangiomas in association with morning glory disc anomaly.

G Holmström1, D Taylor.   

Abstract

PURPOSE AND
METHOD: Capillary haemangiomas in children are usually isolated, but may have systemic associations. This accords with our finding of ocular malformations, especially "morning glory disc anomaly" (MGDA), in three children which are described.
RESULTS: All three children had extensive capillary haemangiomas in combination with MGDA in one eye. One of the children also had microphthalmos in one eye and a partial agenesis of the corpus callosum. Another child had sclerocornea in one eye and congenital heart defects.
CONCLUSION: An association of extensive capillary haemangiomas with MGDA is described. The embryological timing of such defects as well as investigation of the children is discussed. Extensive haemangiomas have not previously, to our knowledge, been described in association with MGDA.

Entities:  

Mesh:

Year:  1998        PMID: 9826051     DOI: 10.1034/j.1600-0420.1998.760521.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  4 in total

1.  Evaluation of congenital excavated optic disc anomalies with spectral-domain and swept-source optical coherence tomography.

Authors:  Kyoung Min Lee; Se Joon Woo; Jeong-Min Hwang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-07       Impact factor: 3.117

2.  Unilateral morning glory optic disc anomaly in a case with Down syndrome.

Authors:  Ahmet Altun; Gulengul Altun; Sevda Aydin Kurna; Osman Okan Olcaysu; Suat Fazil Aki
Journal:  BMC Ophthalmol       Date:  2014-04-13       Impact factor: 2.209

3.  Clinical characteristics and treatment of 22 eyes of morning glory syndrome associated with persistent hyperplastic primary vitreous.

Authors:  Ping Fei; Qi Zhang; Jing Li; Peiquan Zhao
Journal:  Br J Ophthalmol       Date:  2013-07-22       Impact factor: 4.638

4.  Morning glory disc anomaly and facial hemangiomas in a girl with moyamoya syndrome.

Authors:  Sanitha Sathyan; Mariea Chackochan
Journal:  Indian J Ophthalmol       Date:  2018-11       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.